4.7 Letter

COVID-19-associated acute disseminated encephalomyelitis (ADEM)

Journal

JOURNAL OF NEUROLOGY
Volume 267, Issue 10, Pages 2799-2802

Publisher

SPRINGER HEIDELBERG
DOI: 10.1007/s00415-020-09951-9

Keywords

ADEM; Post-infectious; COVID-19; Coronavirus; Demyelinating disease

Ask authors/readers for more resources

A 51-year-old woman with COVID-19 infection developed coma and an impaired oculocephalic response to one side. MRI of the brain demonstrated acute multifocal demyelinating lesions, and CSF testing did not identify a direct cerebral infection. High-dose steroids followed by a course of IVIG was administered, and the patient regained consciousness over the course of several weeks. As more patients reach the weeks after initial infection with COVID-19, acute disseminated encephalomyelitis should be considered a potentially treatable cause of profound encephalopathy or multifocal neurological deficits.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available